Hyperoside ameliorates cerebral ischaemic-reperfusion injury by opening the TRPV4 channel < em > in vivo < /em > through the IP < sub > 3 < /sub > -PKC signalling pathway
CONCLUSIONS: Although Hyp showed protective effect in ischaemic stroke, more clinical trial certification is needed due to the difference between animals and humans.PMID:37410551 | DOI:10.1080/13880209.2023.2228379
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Authors: Lei Shi Chenchen Jiang Hanghang Xu Jiangping Wu Jiajun Lu Yuxiang He Xiuyun Yin Zhuo Chen Di Cao Xuebin Shen Xuefeng Hou Jun Han Source Type: research
More News: Biology | Brain | Clinical Trials | Drugs & Pharmacology | Ischemic Stroke | Neurology | Stroke